Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @JonathanStineMD
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @JonathanStineMD
-
Well done
@JenLaiLiverDoc! An inspiration to all junior hepatologists!https://twitter.com/ebtapper/status/1225069272042360832 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thanks for the RT
@AASLDtweetsPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
While ACUTE #exercise reduces portal flow up to 80%, CHRONIC exercise#training does NOT CHANGE portal flow BUT
HVPG significantly reduced in over 2 out of 5 subjects in SportDiet study @docberza@jcgarciapagan and colleagues@HEP_Journal@AASLDtweets https://aasldpubs.onlinelibrary.wiley.com/doi/epdf/10.1002/hep.28992 …pic.twitter.com/gzQWZfQSm0
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
New article coming soon from our research group on
#NAFLD#NASH risk of#thrombosis including possibility for#exercise to improve this https://buff.ly/2OqVJ8P pic.twitter.com/IoU6Cmusx6
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Guidance on
#NAFLD#HCC from@AGA_Gastro authored by@DrLoomba et al. is out! Biggest take away-my argument for screening#NASH patients with#Advanced#Fibrosis for#HCC is endorsed if have either Clinical Decision Aid or Biomarker + Elasto showing F3https://www.gastrojournal.org/article/S0016-5085(20)30127-X/fulltext …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
This highlights the need for more accurate
#biomarkers for#NAFLD diagnosis,#disease#severity and#prognostication. ALT is a poor marker.#livertwitterhttps://twitter.com/parulsood/status/1224201031942193152 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
More from
#IanWanless about parenchymal extinction!#cirrhosis#pathophysiology#LiverTwitterhttps://twitter.com/JuanAbraldes/status/1223622106392363010 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Jonathan G. Stine, MD MSc, FACP proslijedio/la je Tweet
Thinking of a special way to honor your mentor? Check out the
@AASLDFoundation Memorial Travel Award. https://bit.ly/2lMKUmh#mentors#mentorshipHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Post hoc STOPAH analysis shows AUROC for transferrin is not great at 0.72 but similar to MELD, MDF and GAH scores for short and intermediate term mortality predictionhttps://twitter.com/LorettaJophlin/status/1222713898425602048 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Doing my best to walk the walk as an
#exercise advocate for#NAFLD ,#NASH,#HCC and#cirrhosis by ascending@onepeloton leaderboard tonight...#fitness#ExerciseIsMedicinepic.twitter.com/R3tspAyBab
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Consensus opinion from
#LiverTwitter is to not use ASA for chemoprevention for either HCC or cholangio. Anyone have#comments on why they don't do this despite multiple#metaanalyses showing significant#benefit in each#cancer? https://twitter.com/JonathanStineMD/status/1220765585740529664 …pic.twitter.com/vPDdw5GZVL
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Looking for
#advocacy and#support for your#NASH and#NAFLD patients including those who require#transplantation or have HCC? Check out@KnowledgeNash website athttps://www.nash-now.orgHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Alright
#LiverTwitter- do you use aspirin as chemo prevention for either HCC or cholangio?Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
As a former
@AASLDFoundation awardee I can attest to the great benefit your donation will make in the career development of junior hepatologists and#physician#scientists. Your gift funds#groundbreaking#research@AASLDtweetshttps://twitter.com/AASLDFoundation/status/1220354252947755012 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Check out the
@abc27News program featuring our NASHFit Trial. Special is called Penn State Health- Clinical Trials: Research + You Full Broadcast https://youtu.be/nCI4GD2r62Q via@YouTube#NASHSig#NAFLD#FattyLiver#exercise#Clinicaltrial#researchHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Looking forward to DOM annual state of the department lecture
#TomMa@PennStHershey@PSUresearchpic.twitter.com/YQzoACsc3J
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Will have to see how this shakes out for equity and access to
#LiverTransplanthttps://twitter.com/AnjanaPillaiMD/status/1218906598778732544 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.
Improves
Protects against
Decrease in
FFP